Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04335383` - Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies
Not yet recruiting	`NCT06035055` - Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis	Phase 4
Completed	`NCT00774072` - Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization	Phase 2
Completed	`NCT00515229` - Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo	Phase 2
Terminated	`NCT00333385` - Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis	Phase 4
Recruiting	`NCT03638830` - Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa	Phase 2
Enrolling by invitation	`NCT05880069` - Clinical Outcomes in Patients With Infection by Resistant Microorganism
Completed	`NCT00633191` - Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis	Phase 1/Phase 2
Completed	`NCT00712166` - Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa	Phase 3
Recruiting	`NCT04171817` - Animal-Assisted Visitation Program Chlorhexidine Trial	Phase 4
Completed	`NCT01319253` - A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies	N/A
Recruiting	`NCT05282082` - Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
Recruiting	`NCT04803695` - Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease
Not yet recruiting	`NCT05632315` - PMT for MDRO Decolonization	Phase 2
Completed	`NCT01055847` - Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection	Phase 2
Completed	`NCT01745796` - Impact of the Contamination Mode on the Clinical Evolution During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia (PYO GEN)
Recruiting	`NCT04673175` - Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation	Phase 1/Phase 2
Terminated	`NCT05210387` - Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections	N/A
Recruiting	`NCT05616221` - Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection	Phase 2
Terminated	`NCT03262142` - Targeted AntiBiotics for Chronic Pulmonary Diseases	Phase 4

NCT number	NCT02696902
Study type	Interventional
Source	MedImmune LLC
Contact
Status	Completed
Phase	Phase 2
Start date	March 25, 2016
Completion date	December 4, 2019

Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects — EVADE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms